N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV
- N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV
- 라메쉬; Prakash Ramalingam; Subramaniyan Ramasundaram; Do Yang Kim; 박귀덕; Mohan K. Ramasamy; Kyoung Jin Choi
- Trimethyl chitosan; Nanoparticles; Controlled intranasal delivery; Atomic force microscopy; In vivo immunological study
- Issue Date
- Carbohydrate polymers
- VOL 89, NO 4, 1289-1297
- Hepatitis B virus surface antigen (HBsAg) loaded N,N,N-trimethyl chitosan nanoparticles (N-TMC NPs) were formulated and studied for controlled intranasal delivery. The size and surface properties of the NPs can be tuned by modifying the concentration of N-TMC and found to be 66 ± 13, 76 ± 9 nm for 0.25 and 0.5 wt.% respectively. Loading of 380 and 760 μl of HBsAg yielded 143 ± 33, 259 ± 47 nm sized spherical N-TMC NPs with highest loading efficiency and capacity of 90–93%, and 96–97% respectively. In vitro drug release analysis ensured 93% cumulative release of HBsAg antigen over prolonged period (43 days). In vivo immunological study was performed using 6–8 weeks old female BALB mice and reveals adjuvants efficiency of NPs for antigen is highly stable and better than standard. Obtained results show that N-TMC NPs can be extensively used in controlled intra nasal delivery to treat various diseases including hepatitis B and allergic rhinitis.
- Appears in Collections:
- KIST Publication > Article
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.